384 related articles for article (PubMed ID: 20464616)
1. The efficacy of withdrawal therapy in subjects with chronic daily headache and medication overuse following prophylaxis with topiramate and amitriptyline.
Valguarnera F; Tanganelli P
Neurol Sci; 2010 Jun; 31 Suppl 1():S175-7. PubMed ID: 20464616
[TBL] [Abstract][Full Text] [Related]
2. Transformed migraine and medication overuse in a tertiary headache centre--clinical characteristics and treatment outcomes.
Bigal ME; Rapoport AM; Sheftell FD; Tepper SJ; Lipton RB
Cephalalgia; 2004 Jun; 24(6):483-90. PubMed ID: 15154858
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of pregabalin versus topiramate in the prophylaxis of chronic daily headache with analgesic overuse: an open-label prospective study.
Rizzato B; Leone G; Misaggi G; Zivi I; Diomedi M
Clin Neuropharmacol; 2011; 34(2):74-8. PubMed ID: 21412201
[TBL] [Abstract][Full Text] [Related]
4. A randomized trial comparing amitriptyline versus topiramate for the prophylaxis of chronic daily headache in pediatric patients.
Sezer T; Kandemir H; Alehan F
Int J Neurosci; 2013 Aug; 123(8):553-6. PubMed ID: 23421731
[TBL] [Abstract][Full Text] [Related]
5. Chronic daily headache: correlation between the 2004 and the 1988 International Headache Society diagnostic criteria.
Bigal ME; Tepper SJ; Sheftell FD; Rapoport AM; Lipton RB
Headache; 2004; 44(7):684-91. PubMed ID: 15209691
[TBL] [Abstract][Full Text] [Related]
6. The classification of chronic daily headache in adolescents--a comparison between the second edition of the international classification of headache disorders and alternative diagnostic criteria.
Bigal ME; Rapoport AM; Tepper SJ; Sheftell FD; Lipton RB
Headache; 2005 May; 45(5):582-9. PubMed ID: 15953277
[TBL] [Abstract][Full Text] [Related]
7. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.
Dodick DW; Freitag F; Banks J; Saper J; Xiang J; Rupnow M; Biondi D; Greenberg SJ; Hulihan J;
Clin Ther; 2009 Mar; 31(3):542-59. PubMed ID: 19393844
[TBL] [Abstract][Full Text] [Related]
8. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
[TBL] [Abstract][Full Text] [Related]
9. Preliminary results of a withdrawal and detoxification therapeutic regimen in patients with probable chronic migraine and probable medication overuse headache.
Trucco M; Meineri P; Ruiz L;
J Headache Pain; 2005 Sep; 6(4):334-7. PubMed ID: 16362704
[TBL] [Abstract][Full Text] [Related]
10. Effect of valproic acid on withdrawal therapy in patients with overuse of chronic daily headache medications.
Coskun O; Ucler S; Cavdar L; Inan LE
J Clin Neurosci; 2007 Apr; 14(4):334-9. PubMed ID: 16647854
[TBL] [Abstract][Full Text] [Related]
11. Topiramate in patients with episodic migraine: reducing the risk for chronic forms of headache.
Limmroth V; Biondi D; Pfeil J; Schwalen S
Headache; 2007 Jan; 47(1):13-21. PubMed ID: 17355489
[TBL] [Abstract][Full Text] [Related]
12. Medication overuse headache: withdrawal and prophylactic therapeutic regimen.
Trucco M; Meineri P; Ruiz L; Gionco M;
Headache; 2010 Jun; 50(6):989-97. PubMed ID: 20236349
[TBL] [Abstract][Full Text] [Related]
13. Outcomes and predictors of chronic daily headache in adolescents: a 2-year longitudinal study.
Wang SJ; Fuh JL; Lu SR; Juang KD
Neurology; 2007 Feb; 68(8):591-6. PubMed ID: 17182975
[TBL] [Abstract][Full Text] [Related]
14. [Management of chronic daily headache in children and adolescents].
Cuvellier JC
Rev Neurol (Paris); 2009; 165(6-7):521-31. PubMed ID: 19041108
[TBL] [Abstract][Full Text] [Related]
15. Patterns of medication use by chronic and episodic headache sufferers in the general population: results from the frequent headache epidemiology study.
Scher AI; Lipton RB; Stewart WF; Bigal M
Cephalalgia; 2010 Mar; 30(3):321-8. PubMed ID: 19614708
[TBL] [Abstract][Full Text] [Related]
16. Predictors of a negative response to topiramate therapy in patients with chronic migraine.
Rothrock JF; Parada VA; Drinkard R; Zweifler RM; Key KF
Headache; 2005; 45(7):932-5. PubMed ID: 15985112
[TBL] [Abstract][Full Text] [Related]
17. Pilot study of amitriptyline in the prophylactic treatment of medication-overuse headache: a 1-year follow-up.
Fan W; Lv Y; Ying G; Li W; Zhou J
Pain Med; 2014 Oct; 15(10):1803-10. PubMed ID: 25159678
[TBL] [Abstract][Full Text] [Related]
18. Topiramate intervention to prevent transformation of episodic migraine: the topiramate INTREPID study.
Lipton RB; Silberstein S; Dodick D; Cady R; Freitag F; Mathew N; Biondi DM; Ascher S; Olson WH; Hulihan J
Cephalalgia; 2011 Jan; 31(1):18-30. PubMed ID: 20974598
[TBL] [Abstract][Full Text] [Related]
19. Chronic daily headache in adolescents: prevalence, impact, and medication overuse.
Wang SJ; Fuh JL; Lu SR; Juang KD
Neurology; 2006 Jan; 66(2):193-7. PubMed ID: 16434652
[TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.
Dodick DW; Mauskop A; Elkind AH; DeGryse R; Brin MF; Silberstein SD;
Headache; 2005 Apr; 45(4):315-24. PubMed ID: 15836567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
